<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DDI-DrugBank.d458">
    <sentence id="DDI-DrugBank.d458.s0" text="Ketoconazole is a potent inhibitor of the cytochrome P450 3A4 enzyme system.">
        <entity charOffset="0-11" id="DDI-DrugBank.d458.s0.e0" text="Ketoconazole" type="drug"/>
    </sentence>
    <sentence id="DDI-DrugBank.d458.s1" text="Coadministration of NIZORAL  Tablets and drugs primarily metabolized by the cytochrome P450 3A4 enzyme system may result in increased plasma concentrations of the drugs that could increase or prolong both therapeutic and adverse effects.">
        <entity charOffset="20-26" id="DDI-DrugBank.d458.s1.e0" text="NIZORAL" type="brand"/>
    </sentence>
    <sentence id="DDI-DrugBank.d458.s2" text="Therefore, unless otherwise specified, appropriate dosage adjustments may be necessary."/>
    <sentence id="DDI-DrugBank.d458.s3" text="The following drug interactions have been identified involving NIZORAL Tablets and other drugs metabolized by the cytochrome P450 3A4 enzyme system: Ketoconazole tablets inhibit the metabolism of terfenadine, resulting in an increased plasma concentration of terfenadine and a delay in the elimination of its acid metabolite.">
        <entity charOffset="63-69" id="DDI-DrugBank.d458.s3.e0" text="NIZORAL" type="brand"/>
        <entity charOffset="149-160" id="DDI-DrugBank.d458.s3.e1" text="Ketoconazole" type="drug"/>
        <entity charOffset="196-206" id="DDI-DrugBank.d458.s3.e2" text="terfenadine" type="drug"/>
        <entity charOffset="259-269" id="DDI-DrugBank.d458.s3.e3" text="terfenadine" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d458.s3.e0" e2="DDI-DrugBank.d458.s3.e1" id="DDI-DrugBank.d458.s3.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d458.s3.e0" e2="DDI-DrugBank.d458.s3.e2" id="DDI-DrugBank.d458.s3.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d458.s3.e0" e2="DDI-DrugBank.d458.s3.e3" id="DDI-DrugBank.d458.s3.p2"/>
        <pair ddi="true" e1="DDI-DrugBank.d458.s3.e1" e2="DDI-DrugBank.d458.s3.e2" id="DDI-DrugBank.d458.s3.p3" type="mechanism"/>
        <pair ddi="false" e1="DDI-DrugBank.d458.s3.e1" e2="DDI-DrugBank.d458.s3.e3" id="DDI-DrugBank.d458.s3.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d458.s3.e2" e2="DDI-DrugBank.d458.s3.e3" id="DDI-DrugBank.d458.s3.p5"/>
    </sentence>
    <sentence id="DDI-DrugBank.d458.s4" text="The increased plasma concentration of terfenadine or its metabolite may result in prolonged QT intervals.">
        <entity charOffset="38-48" id="DDI-DrugBank.d458.s4.e0" text="terfenadine" type="drug"/>
    </sentence>
    <sentence id="DDI-DrugBank.d458.s5" text="Pharmacokinetic data indicate that oral ketoconazole inhibits the metabolism of astemizole, resulting in elevated plasma levels of astemizole and its active metabolite desmethylastemizole which may prolong QT intervals.">
        <entity charOffset="40-51" id="DDI-DrugBank.d458.s5.e0" text="ketoconazole" type="drug"/>
        <entity charOffset="80-89" id="DDI-DrugBank.d458.s5.e1" text="astemizole" type="drug"/>
        <entity charOffset="131-140" id="DDI-DrugBank.d458.s5.e2" text="astemizole" type="drug"/>
        <entity charOffset="168-186" id="DDI-DrugBank.d458.s5.e3" text="desmethylastemizole" type="drug_n"/>
        <pair ddi="true" e1="DDI-DrugBank.d458.s5.e0" e2="DDI-DrugBank.d458.s5.e1" id="DDI-DrugBank.d458.s5.p0" type="effect"/>
        <pair ddi="false" e1="DDI-DrugBank.d458.s5.e0" e2="DDI-DrugBank.d458.s5.e2" id="DDI-DrugBank.d458.s5.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d458.s5.e0" e2="DDI-DrugBank.d458.s5.e3" id="DDI-DrugBank.d458.s5.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d458.s5.e1" e2="DDI-DrugBank.d458.s5.e2" id="DDI-DrugBank.d458.s5.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d458.s5.e1" e2="DDI-DrugBank.d458.s5.e3" id="DDI-DrugBank.d458.s5.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d458.s5.e2" e2="DDI-DrugBank.d458.s5.e3" id="DDI-DrugBank.d458.s5.p5"/>
    </sentence>
    <sentence id="DDI-DrugBank.d458.s6" text="Coadministration of astemizole with ketoconazole tablets is therefore contraindicated.">
        <entity charOffset="20-29" id="DDI-DrugBank.d458.s6.e0" text="astemizole" type="drug"/>
        <entity charOffset="36-47" id="DDI-DrugBank.d458.s6.e1" text="ketoconazole" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d458.s6.e0" e2="DDI-DrugBank.d458.s6.e1" id="DDI-DrugBank.d458.s6.p0" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d458.s7" text="Human pharmacokinetics data indicate that oral ketoconazole potently inhibits the metabolism of cisapride resulting in a mean eight-fold increase in AUC of cisapride.">
        <entity charOffset="47-58" id="DDI-DrugBank.d458.s7.e0" text="ketoconazole" type="drug"/>
        <entity charOffset="96-104" id="DDI-DrugBank.d458.s7.e1" text="cisapride" type="drug"/>
        <entity charOffset="156-164" id="DDI-DrugBank.d458.s7.e2" text="cisapride" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d458.s7.e0" e2="DDI-DrugBank.d458.s7.e1" id="DDI-DrugBank.d458.s7.p0" type="mechanism"/>
        <pair ddi="false" e1="DDI-DrugBank.d458.s7.e0" e2="DDI-DrugBank.d458.s7.e2" id="DDI-DrugBank.d458.s7.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d458.s7.e1" e2="DDI-DrugBank.d458.s7.e2" id="DDI-DrugBank.d458.s7.p2"/>
    </sentence>
    <sentence id="DDI-DrugBank.d458.s8" text="Data suggest that coadministration of oral ketoconazole and cisapride can result in prolongation of the QT interval on the ECG.">
        <entity charOffset="43-54" id="DDI-DrugBank.d458.s8.e0" text="ketoconazole" type="drug"/>
        <entity charOffset="60-68" id="DDI-DrugBank.d458.s8.e1" text="cisapride" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d458.s8.e0" e2="DDI-DrugBank.d458.s8.e1" id="DDI-DrugBank.d458.s8.p0" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d458.s9" text="Therefore concomitant administration of ketoconazole tablets with cisapride is contraindicated.">
        <entity charOffset="40-51" id="DDI-DrugBank.d458.s9.e0" text="ketoconazole" type="drug"/>
        <entity charOffset="66-74" id="DDI-DrugBank.d458.s9.e1" text="cisapride" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d458.s9.e0" e2="DDI-DrugBank.d458.s9.e1" id="DDI-DrugBank.d458.s9.p0" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d458.s10" text="Ketoconazole tablets may alter the metabolism of cyclosporine, tacrolimus, and methylprednisolone, resulting in elevated plasma concentrations of the latter drugs.">
        <entity charOffset="0-11" id="DDI-DrugBank.d458.s10.e0" text="Ketoconazole" type="drug"/>
        <entity charOffset="49-60" id="DDI-DrugBank.d458.s10.e1" text="cyclosporine" type="drug"/>
        <entity charOffset="63-72" id="DDI-DrugBank.d458.s10.e2" text="tacrolimus" type="drug"/>
        <entity charOffset="79-96" id="DDI-DrugBank.d458.s10.e3" text="methylprednisolone" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d458.s10.e0" e2="DDI-DrugBank.d458.s10.e1" id="DDI-DrugBank.d458.s10.p0" type="mechanism"/>
        <pair ddi="true" e1="DDI-DrugBank.d458.s10.e0" e2="DDI-DrugBank.d458.s10.e2" id="DDI-DrugBank.d458.s10.p1" type="mechanism"/>
        <pair ddi="true" e1="DDI-DrugBank.d458.s10.e0" e2="DDI-DrugBank.d458.s10.e3" id="DDI-DrugBank.d458.s10.p2" type="mechanism"/>
        <pair ddi="false" e1="DDI-DrugBank.d458.s10.e1" e2="DDI-DrugBank.d458.s10.e2" id="DDI-DrugBank.d458.s10.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d458.s10.e1" e2="DDI-DrugBank.d458.s10.e3" id="DDI-DrugBank.d458.s10.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d458.s10.e2" e2="DDI-DrugBank.d458.s10.e3" id="DDI-DrugBank.d458.s10.p5"/>
    </sentence>
    <sentence id="DDI-DrugBank.d458.s11" text="Dosage adjustment may be required if cyclosporine, tacrolimus, or methylprednisolone are given concomitantly with NIZORAL  Tablets.">
        <entity charOffset="37-48" id="DDI-DrugBank.d458.s11.e0" text="cyclosporine" type="drug"/>
        <entity charOffset="51-60" id="DDI-DrugBank.d458.s11.e1" text="tacrolimus" type="drug"/>
        <entity charOffset="66-83" id="DDI-DrugBank.d458.s11.e2" text="methylprednisolone" type="drug"/>
        <entity charOffset="114-120" id="DDI-DrugBank.d458.s11.e3" text="NIZORAL" type="brand"/>
        <pair ddi="false" e1="DDI-DrugBank.d458.s11.e0" e2="DDI-DrugBank.d458.s11.e1" id="DDI-DrugBank.d458.s11.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d458.s11.e0" e2="DDI-DrugBank.d458.s11.e2" id="DDI-DrugBank.d458.s11.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d458.s11.e0" e2="DDI-DrugBank.d458.s11.e3" id="DDI-DrugBank.d458.s11.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d458.s11.e1" e2="DDI-DrugBank.d458.s11.e2" id="DDI-DrugBank.d458.s11.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d458.s11.e1" e2="DDI-DrugBank.d458.s11.e3" id="DDI-DrugBank.d458.s11.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d458.s11.e2" e2="DDI-DrugBank.d458.s11.e3" id="DDI-DrugBank.d458.s11.p5"/>
    </sentence>
    <sentence id="DDI-DrugBank.d458.s12" text="Coadministration of NIZORAL  Tablets with midazolam or triazolam has resulted in elevated plasma concentrations of the latter two drugs.">
        <entity charOffset="20-26" id="DDI-DrugBank.d458.s12.e0" text="NIZORAL" type="brand"/>
        <entity charOffset="42-50" id="DDI-DrugBank.d458.s12.e1" text="midazolam" type="drug"/>
        <entity charOffset="55-63" id="DDI-DrugBank.d458.s12.e2" text="triazolam" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d458.s12.e0" e2="DDI-DrugBank.d458.s12.e1" id="DDI-DrugBank.d458.s12.p0" type="mechanism"/>
        <pair ddi="true" e1="DDI-DrugBank.d458.s12.e0" e2="DDI-DrugBank.d458.s12.e2" id="DDI-DrugBank.d458.s12.p1" type="mechanism"/>
        <pair ddi="false" e1="DDI-DrugBank.d458.s12.e1" e2="DDI-DrugBank.d458.s12.e2" id="DDI-DrugBank.d458.s12.p2"/>
    </sentence>
    <sentence id="DDI-DrugBank.d458.s13" text="This may potentiate and prolong hypnotic and sedative effects, especially with repeated dosing or chronic administration of these agents."/>
    <sentence id="DDI-DrugBank.d458.s14" text="These agents should not be used in patients treated with NIZORAL  Tablets.">
        <entity charOffset="57-63" id="DDI-DrugBank.d458.s14.e0" text="NIZORAL" type="brand"/>
    <negationtags>These agents should &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; be used in patients treated with NIZORAL Tablets. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d458.s15" text="If midazolam is administered parenterally, special precaution is required since the sedative effect may be prolonged.">
        <entity charOffset="3-11" id="DDI-DrugBank.d458.s15.e0" text="midazolam" type="drug"/>
    </sentence>
    <sentence id="DDI-DrugBank.d458.s16" text="Rare cases of elevated plasma concentrations of digoxin have been reported.">
        <entity charOffset="48-54" id="DDI-DrugBank.d458.s16.e0" text="digoxin" type="drug"/>
    </sentence>
    <sentence id="DDI-DrugBank.d458.s17" text="It is not clear whether this was due to the combination of therapy."><negationtags>It is &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; clear whether this was due to the combination of therapy. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d458.s18" text="It is, therefore, advisable to monitor digoxin concentrations in patients receiving ketoconazole.">
        <entity charOffset="39-45" id="DDI-DrugBank.d458.s18.e0" text="digoxin" type="drug"/>
        <entity charOffset="84-95" id="DDI-DrugBank.d458.s18.e1" text="ketoconazole" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d458.s18.e0" e2="DDI-DrugBank.d458.s18.e1" id="DDI-DrugBank.d458.s18.p0" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d458.s19" text="When taken orally , imidazole compounds like ketoconazole may enhance the anticoagulant effect of coumarin-like drugs.">
        <entity charOffset="20-38" id="DDI-DrugBank.d458.s19.e0" text="imidazole compounds" type="group"/>
        <entity charOffset="45-56" id="DDI-DrugBank.d458.s19.e1" text="ketoconazole" type="drug"/>
        <entity charOffset="98-105" id="DDI-DrugBank.d458.s19.e2" text="coumarin" type="group"/>
        <pair ddi="false" e1="DDI-DrugBank.d458.s19.e0" e2="DDI-DrugBank.d458.s19.e1" id="DDI-DrugBank.d458.s19.p0"/>
        <pair ddi="true" e1="DDI-DrugBank.d458.s19.e0" e2="DDI-DrugBank.d458.s19.e2" id="DDI-DrugBank.d458.s19.p1" type="effect"/>
        <pair ddi="true" e1="DDI-DrugBank.d458.s19.e1" e2="DDI-DrugBank.d458.s19.e2" id="DDI-DrugBank.d458.s19.p2" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d458.s20" text="In simultaneous treatment with imidazole drugs and coumarin drugs, the anticoagulant effect should be carefully titrated and monitored.">
        <entity charOffset="31-45" id="DDI-DrugBank.d458.s20.e0" text="imidazole drugs" type="group"/>
        <entity charOffset="51-64" id="DDI-DrugBank.d458.s20.e1" text="coumarin drugs" type="group"/>
        <pair ddi="true" e1="DDI-DrugBank.d458.s20.e0" e2="DDI-DrugBank.d458.s20.e1" id="DDI-DrugBank.d458.s20.p0" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d458.s21" text="Because severe hypoglycemia has been reported in patients concomitantly receiving oral miconazole (an imidazole) and oral hypoglycemic agents, such a potential interaction involving the latter agents when used concomitantly with ketoconazole tablets (an imidazole) can not be ruled out.">
        <entity charOffset="87-96" id="DDI-DrugBank.d458.s21.e0" text="miconazole" type="drug"/>
        <entity charOffset="102-110" id="DDI-DrugBank.d458.s21.e1" text="imidazole" type="group"/>
        <entity charOffset="122-140" id="DDI-DrugBank.d458.s21.e2" text="hypoglycemic agents" type="group"/>
        <entity charOffset="229-240" id="DDI-DrugBank.d458.s21.e3" text="ketoconazole" type="drug"/>
        <entity charOffset="254-262" id="DDI-DrugBank.d458.s21.e4" text="imidazole" type="group"/>
        <pair ddi="false" e1="DDI-DrugBank.d458.s21.e0" e2="DDI-DrugBank.d458.s21.e1" id="DDI-DrugBank.d458.s21.p0"/>
        <pair ddi="true" e1="DDI-DrugBank.d458.s21.e0" e2="DDI-DrugBank.d458.s21.e2" id="DDI-DrugBank.d458.s21.p1" type="effect"/>
        <pair ddi="false" e1="DDI-DrugBank.d458.s21.e0" e2="DDI-DrugBank.d458.s21.e3" id="DDI-DrugBank.d458.s21.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d458.s21.e0" e2="DDI-DrugBank.d458.s21.e4" id="DDI-DrugBank.d458.s21.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d458.s21.e1" e2="DDI-DrugBank.d458.s21.e2" id="DDI-DrugBank.d458.s21.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d458.s21.e1" e2="DDI-DrugBank.d458.s21.e3" id="DDI-DrugBank.d458.s21.p5"/>
        <pair ddi="false" e1="DDI-DrugBank.d458.s21.e1" e2="DDI-DrugBank.d458.s21.e4" id="DDI-DrugBank.d458.s21.p6"/>
        <pair ddi="false" e1="DDI-DrugBank.d458.s21.e2" e2="DDI-DrugBank.d458.s21.e3" id="DDI-DrugBank.d458.s21.p7"/>
        <pair ddi="false" e1="DDI-DrugBank.d458.s21.e2" e2="DDI-DrugBank.d458.s21.e4" id="DDI-DrugBank.d458.s21.p8"/>
        <pair ddi="false" e1="DDI-DrugBank.d458.s21.e3" e2="DDI-DrugBank.d458.s21.e4" id="DDI-DrugBank.d458.s21.p9"/>
    <negationtags>Because severe hypoglycemia has been reported in patients concomitantly receiving oral miconazole (an imidazole) and oral hypoglycemic agents, such a potential interaction involving the latter agents when used concomitantly with ketoconazole tablets (an imidazole) can &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; be ruled out. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d458.s22" text="Concomitant administration of ketoconazole tablets with phenytoin may alter the metabolism of one or both of the drugs.">
        <entity charOffset="30-41" id="DDI-DrugBank.d458.s22.e0" text="ketoconazole" type="drug"/>
        <entity charOffset="56-64" id="DDI-DrugBank.d458.s22.e1" text="phenytoin" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d458.s22.e0" e2="DDI-DrugBank.d458.s22.e1" id="DDI-DrugBank.d458.s22.p0" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d458.s23" text="It is suggested to monitor both ketoconazole and phenytoin.">
        <entity charOffset="32-43" id="DDI-DrugBank.d458.s23.e0" text="ketoconazole" type="drug"/>
        <entity charOffset="49-57" id="DDI-DrugBank.d458.s23.e1" text="phenytoin" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d458.s23.e0" e2="DDI-DrugBank.d458.s23.e1" id="DDI-DrugBank.d458.s23.p0" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d458.s24" text="Concomitant administration of rifampin with ketoconazole tablets reduces the blood levels of the latter.">
        <entity charOffset="30-37" id="DDI-DrugBank.d458.s24.e0" text="rifampin" type="drug"/>
        <entity charOffset="44-55" id="DDI-DrugBank.d458.s24.e1" text="ketoconazole" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d458.s24.e0" e2="DDI-DrugBank.d458.s24.e1" id="DDI-DrugBank.d458.s24.p0" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d458.s25" text="INH (Isoniazid) is also reported to affect ketoconazole concentrations adversely.">
        <entity charOffset="0-2" id="DDI-DrugBank.d458.s25.e0" text="INH" type="drug"/>
        <entity charOffset="5-13" id="DDI-DrugBank.d458.s25.e1" text="Isoniazid" type="drug"/>
        <entity charOffset="43-54" id="DDI-DrugBank.d458.s25.e2" text="ketoconazole" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d458.s25.e0" e2="DDI-DrugBank.d458.s25.e1" id="DDI-DrugBank.d458.s25.p0"/>
        <pair ddi="true" e1="DDI-DrugBank.d458.s25.e0" e2="DDI-DrugBank.d458.s25.e2" id="DDI-DrugBank.d458.s25.p1" type="mechanism"/>
        <pair ddi="true" e1="DDI-DrugBank.d458.s25.e1" e2="DDI-DrugBank.d458.s25.e2" id="DDI-DrugBank.d458.s25.p2" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d458.s26" text="These drugs should not be given concomitantly."><negationtags>These drugs should &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; be given concomitantly. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d458.s27" text="After the coadministration of 200 mg oral ketoconazole twice daily and one 20 mg dose of loratadine to 11 subjects, the AUC and Cmax of loratadine averaged 302% (  142 S.D.) and 251% (  68 S.D.), respectively, of those obtained after co-treatment with placebo.">
        <entity charOffset="42-53" id="DDI-DrugBank.d458.s27.e0" text="ketoconazole" type="drug"/>
        <entity charOffset="89-98" id="DDI-DrugBank.d458.s27.e1" text="loratadine" type="drug"/>
        <entity charOffset="136-145" id="DDI-DrugBank.d458.s27.e2" text="loratadine" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d458.s27.e0" e2="DDI-DrugBank.d458.s27.e1" id="DDI-DrugBank.d458.s27.p0" type="mechanism"/>
        <pair ddi="false" e1="DDI-DrugBank.d458.s27.e0" e2="DDI-DrugBank.d458.s27.e2" id="DDI-DrugBank.d458.s27.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d458.s27.e1" e2="DDI-DrugBank.d458.s27.e2" id="DDI-DrugBank.d458.s27.p2"/>
    </sentence>
    <sentence id="DDI-DrugBank.d458.s28" text="The AUC and Cmax of descarboethoxyloratadine, an active metabolite, averaged 155% (  27 S.D.) and 141% (  35 S.D.), respectively.">
        <entity charOffset="20-43" id="DDI-DrugBank.d458.s28.e0" text="descarboethoxyloratadine" type="drug_n"/>
    </sentence>
    <sentence id="DDI-DrugBank.d458.s29" text="However, no related changes were noted in the QT0 on ECG taken at 2, 6, and 24 hours after the coadministration."><negationtags>However, &lt;scope&gt; &lt;cue&gt; no &lt;/cue&gt; related changes were noted in the QT0 on ECG taken at 2, 6, and 24 hours after the coadministration. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d458.s30" text="Also, there were no clinically significant differences in adverse events when loratadine was administered with or without ketoconazole.">
        <entity charOffset="78-87" id="DDI-DrugBank.d458.s30.e0" text="loratadine" type="drug"/>
        <entity charOffset="122-133" id="DDI-DrugBank.d458.s30.e1" text="ketoconazole" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d458.s30.e0" e2="DDI-DrugBank.d458.s30.e1" id="DDI-DrugBank.d458.s30.p0"/>
    <negationtags>Also, there were &lt;scope&gt; &lt;cue&gt; no &lt;/cue&gt; clinically significant differences in adverse events when loratadine was administered with or without ketoconazole. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d458.s31" text="Rare cases of a disulfiram-like reaction to alcohol have been reported.">
        <entity charOffset="44-50" id="DDI-DrugBank.d458.s31.e0" text="alcohol" type="drug"/>
    </sentence>
    <sentence id="DDI-DrugBank.d458.s32" text="These experiences have been characterized by flushing, rash, peripheral edema, nausea, and headache."/>
    <sentence id="DDI-DrugBank.d458.s33" text="Symptoms resolved within a few hours."><negationtags>Symptoms &lt;scope&gt; &lt;cue&gt; resolved &lt;/cue&gt; within a few hours. &lt;/scope&gt;</negationtags></sentence>
</document>